Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.

Abstract

The purpose of this research is to study the outcomes of splenectomy for chronic and persistent immune thrombocytopenia (ITP). This study is a retrospective analysis of 254 patients with chronic or persistent ITP who underwent splenectomy at CMC, Vellore, India between 1995 and 2009. Responses were assessed based on standard criteria. One hundred and sixty seven adults and 87 children with a median age of 29years (range 2-64) with persistent (n = 103) or chronic ITP (n = 151) was studied. Response was seen in 229 (90.2%) including CR in 74.4% at a median time of 1day (range 1-54). Infections following splenectomy were reported in 16%. Deaths related to post splenectomy sepsis occurred in 1.57% and major bleeding in 0.78%. At median follow-up of 54.3months (range 1-290), 178 (70.1%) remain in remission. The 5-year and 10-year overall survival (OS) is 97.4 ± 1.2% and 94.9 ± 2.1%, respectively, while the 5-year and 10-year event-free survival (EFS) is 76.5 + 2.9% and 71.0 + 3.9%, respectively. Splenectomy is associated with long-term remission rates of >70% in chronic or persistent ITP.